The Journal of Internal Korean Medicine (대한한방내과학회지)

The Society of Internal Korean Medicine (대한한방내과학회)
권호 표지
DOI QR코드

DOI QR Code

Development of a Basic Standard Tool for Pattern Identification of Benign Prostatic Hyperplasia (BPH)

전립선비대증 변증도구 개발 기초 연구

  • Jeong, Ho-young (Dept. of Internal Medicine, College of Oriental Medicine, Dae-Jeon University) ;
  • Lee, Ji-yoon (College of Korean Medicine, Dae-Jeon University) ;
  • Park, Yang-chun (Dept. of Internal Medicine, College of Oriental Medicine, Dae-Jeon University) ;
  • Jung, In-chul (Dept. of Oriental Neuropsychiatry, College of Korean Medicine, Dae-Jeon University) ;
  • Cho, Chung-sik (Dept. of Internal Medicine, College of Oriental Medicine, Dae-Jeon University)
  • 정호영 (대전대학교 한의과대학 신계내과학교실) ;
  • 이지윤 (대전대학교 한의과대학) ;
  • 박양춘 (대전대학교 한의과대학 신계내과학교실) ;
  • 정인철 (대전대학교 한의과대학 신경정신과학교실) ;
  • 조충식 (대전대학교 한의과대학 신계내과학교실)
  • Received : 2016.12.01
  • Accepted : 2016.12.21
  • Published : 2017.06.30
Download PDF
⟨ Previous Next ⟩

Abstract

Objective: The purpose of this study was to develop a standard tool of pattern identification, which will be applied to clinical research, for benign prostatic hyperplasia. Method: The items and structure of the instrument were based on a review of the published literature in China and Korea. The advisory committee on this study included 11 kidney-endocrine professors of the Korean Medical Colleges Division and 4 Korean medicine doctors who had a doctor's degree in the Kidney-Endocrine Division. The advisory committee was questioned regarding pattern identification importance, symptom weight, treatment importance, changes in the symptoms, rare changes in the symptoms, and frequency of prescriptions regarding benign prostatic hyperplasia. Results: The Korean instrument of pattern identification was completed; it was composed of four questions for benign prostatic hyperplasia. Conclusion: We sincerely look forward to improving the instrument through the continuous clinical studies.

Keywords

References

  1. Abrams P. In support of pressure-flow studies for evaluationg men with lower urinary symptoms. Urology 1994;44:153-5. https://doi.org/10.1016/S0090-4295(94)80119-3
  2. Lee WT, Lee JE, Park SH, Lee KL, Park KA, Hong SG. Humanbody anatomical physiological. Seoul: Jungdam; 2004, p. 891-2.
  3. Ahn YM, Ahn SY, Cho DH, Doo HK. The study of oriental and accidental benign prostate hypertrophy. The Korean Oriental Chronic Disease 1(1):85-111.
  4. Arrighi HM, Metter EJ, Guess HA, Fpzzard JL. National history of benign prostatic hyperplasia and risk of prostatectomu. The Baltimore Longitudianl Study of Aging Urology 1991;38(Suppl):4-8.
  5. McConnell JD. Prostate growth: new insights into hormonal regulation. Br J Urol 1995;76(Suppl l):5-10. https://doi.org/10.1111/j.1464-410X.1995.tb07864.x
  6. Coffey DS, Walsh PC. Clinical and experimental studies of benign prostatic hyperplasia. Urol Clin North Am 1990;17:461-75.
  7. Levy A, Samraj GP. Benign prostatic hyperplsia: when to 'watch and wait'. when and how to treat. Cleve Clin J Med 2007;74(3):15-20.
  8. Oh SH, Oh BR, Ryu SB. Effect of finasteride on sexual function in patients with benign prostatic hyperplasia. Korean J Urol 2002;43:611-8.
  9. Choi WS, Moon KH. The effect of finasteride, tamsulosin and doxazosin therapy on sexual function in patients with benign prostatic hyperplasia. Korean J Urol 2004;34:777-82.
  10. Doo HK. Clinical Kidney Medicine. Seoul: Sungbosa; 1995, p. 704-8.
  11. Eum HS, Kim SA, Jung WS, Shin GC, Kang YH. Clinical Report on a Patient with Benign Prostatic Hyperplasia diagnosed as the Deficiency of Yang of the Kidney. The Journal of the Korea institute of oriental medical informatics 2004;10(2):8-16.
  12. Jang ES, Lee EJ, Yun YG, Park YC, Jung IC. Suggestion of Standard Process in Developing Questionnaire of Pattern Identification. Korean Journal of Oriental Physiology & Pathology 2016;30(3):190-200. https://doi.org/10.15188/kjopp.2016.06.30.3.190
  13. Kidney Internal medicine Committee of Korean Medicine. Kidney Internal Medicine. Seoul: Gunjachulpansa; 2015, p. 47-8.
  14. Wang XL. National Standard of the People's Republic of China (中醫病證診斷療效標準). Beijing: State Administration of Traditional Chinese Medicine of the People's Republic of China; 1994, p. 44-5.
  15. Zhou ZY. Chinese Internal Medicine (中醫內科學). Beijing: China Press of Traditional Chinese Medicine; 2003, p. 370-2.
  16. China Association of Chinese Medicine. Diagnosis and Treatment of Common Diseases in Traditional Chinese Medicine(中醫內科常見病診療指南 中醫病證部分). Beijing: China Press of Traditional Chiness Mediicine; 2008, p. 108-9.
  17. Neng BM. Chinese Journal of Clinical Medicine Male Specialized(中醫男科臨床治療學). Beijing: People's Medical Publishing House; 2011, p. 332-9.
  18. Kwak K. Integrated Traditional Chinese and Western Medicine Male Specialized(中西醫結合男科治療學). Beijing: People's Medical Publishing House; 2003, p. 256-8.
  19. Ha CH. Integrative Chinese and Western Medicine Male Specialized(中西醫結合男科學). Beijing: People's Medical Publishing House; 2005, p. 303-4.
  20. Ma YG. Integrative Chinese and Western Medicine Male Specialized(中西醫結合男科學). Beijing: China Press of Traditional Chinese Medicine; 2001, p. 506-8.
  21. Jin JG. Clinical Diagnosis and Treatment of Male Specialized Diseases in Traditional Chinese Medicine(男科專病中醫臨床診治). Beijing: People's Medical Publishing House; 2013, p. 68-9.
  22. Kim CS. Benign Prostatic Hyperplasia. J Korean Med Assoc 2007;50(7):628-36.
  23. Baisch H, Otto U, Fack H. Growth of human prostate carcinomas with and without hormone alpha-dehydrotestosterone. Eur Urol 1998;34:505-11. https://doi.org/10.1159/000019791
  24. Kavoussi LR, Novick AC, Partin AW, Peters CA, Wein Alan J. eds. Evaluation of the urologic patient: History, physical examination, and urinalysis/Benign prostatic hyperplaisa etiology. pathophysiology, epidemiology, and natural history. Campbell-Walsh urology. 9th ed. Philadelphia: Elsevier Inc; 2007, p. 81-110, 2727-65.
  25. Yoo SH, Chai SE, Kim CB, Kang MG, Song JM, Lee ES, et al. Development of a Clinical Practice Guideline; Benign Prostatic Hyperplasia. Quality improvement in Health Care 1996;3(2):36-51.
  26. Lepor H. Alpha Blockers for the Treatment of Benign Prostatic Hyperplasia. Rev Urol 2007;9(4):181-90.
  27. Fagelman E, Lowe FC. Herbal medications in the treatment of benign prostatic hyperplasia (BPH). Urol Clin North Am 2002 Feb;29(1):23-9. https://doi.org/10.1016/S0094-0143(02)00015-0
  28. Kim JG, Song BG, Lee EJ, Kim HG. Study on the Treatment of Benign Prostatic Hyperplasia (BPH) in Oriental Medicine. The Journal of Korean Oriental Medical Society 1998;19(2):211-27.

Cited by

  1. 전립선 비대증에 대한 뜸치료의 효과 : 체계적 문헌고찰과 메타분석 vol.39, pp.3, 2018, https://doi.org/10.22246/jikm.2018.39.3.372
  2. 주의력결핍 과잉행동장애(ADHD) 한의 변증 설문지 개발 연구 vol.30, pp.1, 2017, https://doi.org/10.7231/jon.2019.30.1.001
  3. 전립선비대증 변증도구의 신뢰도 평가 및 IPSS, 요속과의 상관관계에 대한 탐색적 연구 vol.41, pp.6, 2017, https://doi.org/10.22246/jikm.2020.41.6.1052